Indacaterol - Novartis
At a glance
- Drug Originator Novartis
- Drug Licenced by Glenmark Pharmaceuticals Ltd; Rovi; Sumitomo Pharma America
- Drug Class Antiasthmatics; Bronchodilators; Indans; Quinolones; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists
- USA Patent Applicants NOVARTIS
- USA Patents 13
- NDAs 1
- International Patents 86
- Patent Applications 152
Table of Contents
Disclaimer